Free tool
FAERS Monitor: Sodium Acetate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018893 or its brand name (Sodium Acetate, Sodium Acetate). Reports on generic versions are filed under their own applications.
Reports
285
Serious
229
80% of reports
Hospitalization
134
Death reported
56
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use29
- pyrexia23
- nausea18
- diarrhoea17
- dyspnoea16
- pneumonia16
- vomiting16
- death15
- anaemia14
- condition aggravated13
- drug intolerance13
- fatigue13
- general physical health deterioration13
- asthenia12
- no adverse event12
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 12 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 8 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 14 |
| 2014 | 7 |
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 14 |
| 2018 | 23 |
| 2019 | 26 |
| 2020 | 11 |
| 2021 | 25 |
| 2022 | 20 |
| 2023 | 14 |
| 2024 | 33 |
| 2025 | 15 |
| 2026 | 19 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,874 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug intoleranceSignal | 13 | 9.9 | 5.8 | 96 |
| general physical health deteriorationSignal | 13 | 8.3 | 4.9 | 77 |
| anaemiaSignal | 14 | 5.4 | 3.3 | 47 |
| pyrexiaSignal | 23 | 4.9 | 3.3 | 69 |
| no adverse eventSignal | 12 | 4.9 | 2.8 | 34 |
| pneumoniaSignal | 16 | 3.6 | 2.3 | 29 |
| condition aggravatedSignal | 13 | 3.2 | 1.9 | 17 |
| vomitingSignal | 16 | 2.5 | 1.6 | 13 |
| off label useSignal | 29 | 2.4 | 1.7 | 24 |
| astheniaSignal | 12 | 2.4 | 1.4 | 8 |
| dyspnoeaSignal | 16 | 2.1 | 1.3 | 8 |
| diarrhoea | 17 | 1.9 | 1.2 | 7 |
| nausea | 18 | 1.7 | 1.1 | 4 |
| death | 15 | 1.3 | 0.8 | 1 |
| fatigue | 13 | 1.2 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.